Browse Category

Investment Analysis News 7 December 2025

Vertex Pharmaceuticals (VRTX) Stock on December 7, 2025: Casgevy Breakthrough, Pain-Drug Setbacks and What 2026 Forecasts Are Saying

Vertex Pharmaceuticals (VRTX) Stock on December 7, 2025: Casgevy Breakthrough, Pain-Drug Setbacks and What 2026 Forecasts Are Saying

Updated: December 7, 2025 – For informational purposes only, not investment advice. 1. VRTX stock snapshot as of early December 2025 Vertex Pharmaceuticals (NASDAQ: VRTX) has had a busy—and volatile—2025. As of the close on Friday, December 5, 2025, VRTX
PDD Holdings Inc – ADR Stock on December 7, 2025: Temu Lawsuits, Q3 Earnings Beat and 2026 Price Targets

PDD Holdings Inc – ADR Stock on December 7, 2025: Temu Lawsuits, Q3 Earnings Beat and 2026 Price Targets

As of December 7, 2025, PDD Holdings Inc. – the Dublin‑based parent of Chinese e‑commerce platform Pinduoduo and global bargain marketplace Temu – is back in the headlines. Strong third‑quarter earnings, fresh regulatory scrutiny in the United States and Europe,
LAES Stock on December 7, 2025: SEALSQ’s Quantum Security Bet Faces Volatile Trading and Mixed Forecasts

LAES Stock on December 7, 2025: SEALSQ’s Quantum Security Bet Faces Volatile Trading and Mixed Forecasts

Ticker: LAES (SEALSQ Corp) • Exchange: Nasdaq • Sector: Semiconductors / Cybersecurity / Post‑Quantum Cryptography Snapshot of LAES Stock as of December 7, 2025 SEALSQ Corp (NASDAQ: LAES) goes into the weekend of December 7, 2025 trading at $4.86 per
1 80 81 82 83 84 161
Go toTop